About | Free Trial

Last Update

2015-10-18T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong John Kolman?

Dr. John Kolman L.

Executive Director and Head of Translational Medicine

QPS, LLC

Direct Phone: (302) ***-****       

Email: j***@***.com

QPS Holdings, LLC

QPS, LLC

1 Innovation Way, Suite 200

Newark, Delaware 19711

United States

Company Description

Founded in 1995, QPS is a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development. We provide quality services to pharmaceutical and biotechnology clients worldwide. Our linearly integrated co ... more

Find other employees at this company (1,133)

Background Information

Employment History

Executive Director
BioReliance Corporation

Executive Director, Head
Genomics BioReliance

Executive Director, Head of Genomics
Sigma-Aldrich Corporation

Senior Director, Research and Development
BioCoR Research

Senior Scientist
Invitrogen Corporation

Post Doc and Staff Scientist
Salk Institute

Researcher
Salk Institute

Education

Master's degree
Molecular Biophysics and Biochemistry
Yale University

Master??s degree

PhD
Molecular Biophysics and Biochemistry
Yale University

undergraduate degree cum laude
Honors Biology and Chemistry
University of Illinois

Web References (26 Total References)


Press Releases | BioReliance

www.bioreliance.com [cached]

BioReliance Corporation announced today that John L. Kolman, PhD, has been named Senior Director, Research and Development.


John L. Kolman, ...

www.isbiotech.org [cached]

John L. Kolman, PhD

Independent Consultant


John L. Kolman, ...

www.isbiotech.org [cached]

John L. Kolman, PhD

Independent Consultant


John Kolman, Global Head of ...

www.pda.org [cached]

John Kolman, Global Head of R&D, BioReliance Ltd.

Dr. John Kolman joined BioReliance in April of 2008 as head of the newly formed Global Research and Development as well as the Department of Genomics. Prior to that, he was a Principal Scientist in the Corporate Research Laboratory of Invitrogen Corp. There, he built collaborations with academic thought leaders and led cross-department teams in the application of cutting edge technologies to novel, high-impact areas.
John received his Ph.D from Yale University for the study of molecular events underpinning Epstein-Barr virus lytic activation. He then continued with a post-doctoral appointment at the Salk Institute, eventually rising to Staff Scientist. His career has been motivated by the study of difficult biological questions using new molecular approaches.


Speaker/Bios « 2011 PDA Annual Meeting

pdaannualmeeting.org [cached]

John Kolman

...
John Kolman
BioReliance
Dr. Kolman joined BioReliance in April of 2008 as head of the newly formed Global Research and Development as well as the Department of Genomics. Prior to that, he was a Principal Scientist in the Corporate Research Laboratory of Invitrogen Corp. There, he built collaborations with academic thought leaders and led cross-department teams in the application of cutting edge technologies to novel, high-impact areas.
John received his Ph.D from Yale University for the study of molecular events underpinning Epstein-Barr virus lytic activation. He then continued with a post-doctoral appointment at the Salk Institute, eventually rising to Staff Scientist. His career has been motivated by the study of difficult biological questions using new molecular approaches.

Similar Profiles

Other People with this Name

Other people with the name Kolman

Beth Kolman
Cisco Systems Inc

Sol Kolman

Valyn Kolman
Sandton

Antonius Kolman
PFTSA

Ann Kolman
Endurance Re

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory